GMED logo

Globus Medical, Inc. Stock Price

NYSE:GMED Community·US$11.0b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 38 Fair Values set on narratives written by author

GMED Share Price Performance

US$86.02
1.53 (1.81%)
US$88.80
Fair Value
US$86.02
1.53 (1.81%)
3.1% undervalued intrinsic discount
US$88.80
Fair Value
Price US$86.02
AnalystConsensusTarget US$88.80
AnalystLowTarget US$65.00
AnalystHighTarget US$105.25

GMED Community Narratives

AnalystConsensusTarget·
Fair Value US$88.8 3.1% undervalued intrinsic discount

Spine Procedure Trends And Robotics Will Shape Industry Position Amid Margin Pressures

0users have liked this narrative
0users have commented on this narrative
17users have followed this narrative
AnalystLowTarget·
Fair Value US$65 32.3% overvalued intrinsic discount

Integration And Supply Risks Will Curb Margins Yet Unlock Value

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AnalystHighTarget·
Fair Value US$106 18.8% undervalued intrinsic discount

Aging Demographics And Digital Trends Will Transform Orthopedic Care

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Updated Narratives

GMED logo

Spine Procedure Trends And Robotics Will Shape Industry Position Amid Margin Pressures

Fair Value: US$88.8 3.1% undervalued intrinsic discount
17 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
GMED logo

Integration And Supply Risks Will Curb Margins Yet Unlock Value

Fair Value: US$65 32.3% overvalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
GMED logo

Aging Demographics And Digital Trends Will Transform Orthopedic Care

Fair Value: US$106 18.8% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with solid track record.

0 Risks
3 Rewards

Globus Medical, Inc. Key Details

US$2.8b

Revenue

US$899.8m

Cost of Revenue

US$1.9b

Gross Profit

US$1.4b

Other Expenses

US$423.8m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
3.17
67.51%
15.30%
0%
View Full Analysis

About GMED

Founded
2003
Employees
5300
CEO
Keith Pfeil
WebsiteView website
www.globusmedical.com

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip and knee joint solutions, including modular hip stems and acetabular cups for total hip arthroplasty, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants; and neuromonitoring services, which provides onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also offers enabling technologies, such as imaging, navigation, and robotics (INR) solutions for assisted surgery, which includes the ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures with screw and interbody spacer placement applications; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative, image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Recent GMED News & Updates

Globus Medical: Straightening Its Back

Nov 11

Recent updates

No updates